The condition most of us have known as PCOS, or polycystic ovary syndrome, was renamed polyendocrine metabolic ovarian syndrome, or PMOS, in May 2026
Research continues, but immediate approval in this indication now appears unlikely
Taking a GLP-1 injection slightly early is generally not harmful, but doses given too close together may increase the risk of side effects such as nausea, vomiting, or abdominal discomfort
Continuous variables were reported as means standard deviation or medians with interquartile range (IQR), as appropriate
Decoding the Good, Bad, and Alternative
Annexes 2024 Annual Report of the European Medicines Agency (includes retatrutide Paediatric Investigation Plan entry)